The Irish Department of Health (DoH) is in the process of developing a national biosimilar medicines policy which aims to increase biosimilar use by creating a robust framework where biologicals and biosimilars can be used safely, cost-effectively, and confidently in the health service. In this example from an Irish teaching hospital, the introduction of the biosimilar first to new patients, along with a switching study executed in parallel, helped to raise prescriber confidence.
Mentoring Scientists
LifeSci NYC held an inspiring STEM Career Panel at the new Flatiron Health office in SoHo. The LifeSci grad student interns shared how some felt inner conflict between the opportunity to launch straight into an exciting tech career vs. slowing down for grad school.
Economic Impact of Comparative-Effectiveness Studies
@AcademyHealth #ARM2018 attendees: join me on Monday at 3:15 pm in room 605-606, where Anirban Basu will present our work in collaboration with the Patient Centered Outcomes Research Institute (PCORI) to quantify the potential economic impact of the findings from comparative-effectiveness research studies. Goal Our goal was to understand the potential benefits of implementing comparative-effectiveness…
How to keep up with new science lit
Resource Roundup: my tips and tricks to efficiently stay informed and learn more about the evolving field of health economics Teaching with the University of Washington’s online certificate program in Health Economics and Outcomes Research (HEOR), students often ask us how to keep up with the constantly changing field after the course series ends. Here is…
Progress in viral suppression shifts distribution of metrics in US states
While preparing a review for the journal Current HIV/AIDS Reports, I uncovered some interesting longitudinal trends in the care cascade and heterogeneity in the progress of US states. The following visualizations describe CDC HIV surveillance data from 2010-2014. They didn’t make the cut for our review paper, and they are too beautiful and interesting to…
The next generation of ISPOR leadership
It has been a privilege to serve and represent more than 5,000 health economics graduate students in 77 countries and support the work of presidents from 107 student chapters during my term as Chair of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Student Network in 2017-2018. Where We Are Today I continue to be…
Defended
On Thursday, May 3, 2018, I defended my doctoral dissertation research in The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute at the University of Washington and became a doctor. Mathematical Models Interrogation The priviledge to ask and answer my own scientific questions was only possible because of the dedicated professors and mentors who gifted…
Investment Round
Lab coats are being ironed, promo stickers wrapped around candy bars, and strangers pulled off the street to help with utility testing. It’s time for the Business Plan Competition.
BBC Interview
On Tuesday, April 17, the journal Nature Scientific Reports published our paper “Projected effectiveness and added value of HIV vaccination campaigns in South Africa: A modeling study.” A few hours later, a reporter from BBC World Service reached out to discuss the the results of our study. Live Interview You can listen to this clip with…
Doctoral Dissertation Defense
An Invitation Please join us at my doctoral dissertation defense titled “Mathematical Models to Evaluate the Clinical and Economic Impact of Biomedical HIV Prevention Strategies in the United States” at 12:30 pm on Thursday, May 3, 2018 at the Washington Research Foundation (WRF) Data Science Studio on the 6th floor of the Physics/Astronomy Tower at the University of Washington…